Protein Profiling Method Reveals Many Potential New Drug Targets
July 31, 2017
LA JOLLA, CA July 31, 2017 Scientists at The Scripps Research Institute (TSRI) have invented a versatile method for identifying proteins that can feasibly be targeted with drugs to treat disease.
Using the new method, published on July 31, 2017 in Nature Chemistry, the TSRI scientists identified more than 100 human proteins that are likely to be targetable with small molecule, pill-based drugs. Some of these proteins already have been implicated in diseases such as cancer, but only a minority were previously known to be druggable.
This new protein profiling method allows us to expand the universe of proteins that can be targeted by small molecules, which in turn should encourage the development of new drugs as well as probes for studying protein biology, said senior investigator Benjamin F. Cravatt, a professor of chemical biology at TSRI.
Determining whether a disease-related protein can react strongly with a small-molecule probe or candidate drug in a way that alters its function is often an essential first step in drug development. Yet broad methods for mapping this important property of proteins have been scarce. Thus, for most of the human repertoire of about 25,000 proteins, scientists simply don't know which ones are druggable.
In response to that need, Cravatt and colleagues have been developing new methods to discover and map the sites on proteins where small-molecule probe can bind. In the past several years, for example, they have invented techniques for identifying druggable sites centered on cysteine or serine amino acids on proteins. With those methods, they have successfully revealed the druggability of hundreds of proteins, many of which had previously been thought un-druggable.
For the new study, the TSRI researchers sought to map druggable sites centered on lysine amino acids. As for cysteines and serines, Cravatt and colleagues found that lysine sites sometimes have a high degree of chemical reactivity, which makes them more likely to be involved in their protein's function and thus potentially good drug targets.
The high reactivity of some lysine sites also means that certain chemical compounds can make a certain type of extra-tight, effectively irreversible bond with them, known as a covalent bond. In principle, a drug molecule that can recognize such a reactive site on a protein and then bind covalently to it will be much more potent than a drug that binds more weakly and reversibly. Covalently binding drugs include old drugs such as aspirin and penicillin, as well as powerful new enzyme inhibitor drugs for treating cancers.
Cravatt and colleagues, including first authors Stephan M. Hacker and Keriann M. Backus, both postdoctoral research associates at the time of the study, started by identifying a chemical compound (pentynoic acid sulfotetrafluorophenyl ester) that can selectively and covalently bind to reactive lysines on proteins. The scientists then used the compound as a probe to characterize the reactivity of more than 4,000 lysines on proteins in human cells.
Of these lysines, 310 met criteria for being abnormally reactive. As expected, the scientists found that these hyper-reactive lysines were unusually likely to be located at functional sites on proteins.
In another experiment, a more direct test of druggability, the researchers used a library of small molecules broadly representing potential drug molecules to see which could compete with the probe in binding covalently to reactive lysines on human proteins. This test revealed 121 lysines in 113 proteins that were clearly targetable with small molecules, and thus are in principle targetable with candidate drug molecules.
For many of these proteins, the observed interactions with small molecules provided the first evidence of their druggability.
The proteins newly revealed to be druggable belong to a variety of functional classes, including enzymes that catalyze biochemical reactions, scaffold proteins that act as hubs for other protein signaling complexes, and transcription factors that regulate gene activity.
To demonstrate the potential usefulness of this method for drug discovery, the researchers selected several of these proteins and showed that the small molecules targeting these proteins also blocked the proteins' functions.
In some cases, the small molecules turned out to work by inhibiting a protein's enzyme activity a very common mechanism for drugs. In other cases, they appeared to work in ways that have traditionally been considered challenging for small-molecule drugs. For example, in the case of the protein SIN3A, a regulator of gene transcription, the small molecule that covalently binds to its reactive lysine blocks the protein's function by disrupting SIN3A's interaction with another protein, TGIF1 an interaction implicated in some invasive breast cancers.
More optimized compounds targeting that same reactive lysine in SIN3A might hinder cancer cell growth and malignancy, and thus might represent a starting point for drug development, said Cravatt.
Having made this proof-of-principle demonstration, Cravatt and colleagues now plan a broader effort to discover small molecules that bind covalently to reactive lysines.
We think this approach has the potential to substantially expand the map of the druggable human proteome, Cravatt said.
Cancer Chemistry Molecular Medicine Cravatt, Benjamin
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
13/05/2026
New Adobe Premiere Color Grading Mode Accelerated on NVIDIA GPUs
Joel Pennington May 13, 2026
0 Comments
New NVIDIA RTX-accelerated features streamlin...
13/05/2026
Grass Valley announced that dB Broadcast has delivered new IP-based outside broadcast (OB) trucks for Cloudbass, featuring Grass Valley LDX 100 Series cameras a...
13/05/2026
Ikegami will exhibit the latest additions to its wide range of broadcast production cameras, control units, viewfinders and monitors on stand 5D3-1 at Broadcast...
13/05/2026
FISE, working with the founding members of the XR Sports Alliance (XRSA), Accedo, Qualcomm Technologies, Inc. and HBS, have collaborated to develop an immersive...
13/05/2026
Canon Unveils New EOS R6 V Full-Frame EOS Camera and RF20-50mm F4 L IS USM PZ Bu...
13/05/2026
Boston Conservatory at Berklee Honors Beth Morrison and Moses Pendleton at Comme...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/05/2026
Creative software developer Foundry today announced the latest developments on Nuke Stage. A purpose-built application for end-to-end virtual production and in-...
13/05/2026
A definitive portrait of one of Ireland's most influential musicians
New TV documentary airs Monday 18 May on RT One and RT Player at 9.35pm
Watch the...
13/05/2026
Agentic AI is changing the way users get work done. Following the success of OpenClaw, the community is embracing new open source agentic frameworks. The latest...
13/05/2026
Reinforcement-learning agents - AI systems that learn by trial and error - can c...
12/05/2026
Beyond the Hype: A Strategic Post-Hoc Analysis of NAB 2026 If NAB Show 2026 had an underlying theme, it was a quiet, industry-wide pivot from the high-energy sp...
12/05/2026
Guntermann and Drunck (G&D), a Panoptec Technologies Group company, and CT Square, led by Chandresh Shah, have announced a joint venture to distribute G&D and V...
12/05/2026
With 30 days until the start of the FIFA World Cup 2026, Telemundo, the exclusive Spanish-language home of the tournament in the United States, has announced th...
12/05/2026
The NHL has announced the return of Stanley Pup for its third consecutive year, a 90-minute special featuring adoptable rescue dogs competing on a miniature rin...
12/05/2026
NBCUniversal presented its 2026 Upfront to advertisers at Radio City Music Hall, detailing upcoming programming across NBC, Peacock, Bravo, and Versant properti...
12/05/2026
FOX Sports has announced funding for the Fandom and Social Connection Initiative at Harvard Kennedy School's Shorenstein Center on Media, Politics, and Publ...
12/05/2026
TNDV and Live Media, both divisions of Live Media Group, supported live broadcast coverage around NCAA Final Four weekend in Indianapolis, including the March M...
12/05/2026
The European Football Alliance (EFA) has announced a content distribution agreement with Fubo Sports Network, the free ad-supported streaming TV (FAST) channel ...
12/05/2026
For the first time, Spanish-speaking fans in the U.S. will have two separate tel...
12/05/2026
CP Communications led a comprehensive spectrum management initiative on behalf of Churchill Downs during Kentucky Derby week, coordinating RF assets across the ...
12/05/2026
LiveU has announced a strategic partnership with DRONERESPONDERS, a 501(c)3 non-...
12/05/2026
Open Broadcast Systems has announced that BMC TV, a specialist in IP transport of broadcast content, has selected the Open Broadcast Systems 5G Flyaway solution...
12/05/2026
NEP Europe, part of NEP Group, has announced it will deliver broadcast solutions...
12/05/2026
Grass Valley has announced continued collaboration with Ravensbourne University ...
12/05/2026
Stats Perform has announced the launch of Opta Pulse, an AI-assisted video creation and distribution platform for leagues, rights holders, and broadcasters. The...
12/05/2026
FOX Sports has announced a collaboration with Sesame Workshop to integrate Sesame Street characters into FOX Sports' FIFA World Cup 2026 programming. Conten...
12/05/2026
To date, NHL Productions has produced 19 broadcasts with commentary in American Sign Language
NHL in ASL (American Sign Language) may be just one show, but the...
12/05/2026
Google's Brian Albert: creators, athletes, highlights, nostalgia, second-scr...
12/05/2026
A still from Past Lives by Celine Song, an official selection of the Premieres program at the 2023 Sundance Film Festival. (Courtesy of Sundance Institute | p...
12/05/2026
Spotify is where fans and artists come together, turning discovery into somethin...
12/05/2026
Features patented Marco-MMC clocking technology
Black Lion Audio's latest release combines the company's expertise in clocking with their renowned p...
12/05/2026
New Track Panel, sequencer upgrades & more
Following their recent public beta release, Reason Studios have announced the full release of Reason 14. With the...
12/05/2026
One month to go! SBS reveals expansive FIFA World Cup 2026 lineup beyond the pi...
12/05/2026
Rohde & Schwarz presents its advanced solutions for power electronics testing at...
12/05/2026
aconnic AG (ISIN: DE000A0LBKW6), Munich, has developed a modified fund raising p...
12/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/05/2026
Tyrell Corporation, specialists in high-end live sports and entertainment broadcasts, was tasked with delivering compelling broadcast coverage of premier equest...
12/05/2026
Registration is now open for IBC2026 as the global media, entertainment and technology community prepares to converge on the RAI Amsterdam from 11 14 September ...
12/05/2026
Ross Video, a global leader in live video production technology, will present its latest innovations and integrated production workflows at BroadcastAsia 2026, ...
12/05/2026
500 selected leaders from around the world across start-ups, corporates, and venture capital. Over 50bn in assets under management among attending investors, a...
Protein Profiling Method Reveals Many Potential New Drug Targets 
